Biomedical Systems Launches Next Generation eCOA Technology
Biomedical Systems, a premier global provider of centralized diagnostic services, launches its second generation clinical outcome assessment software offering three easy-to-use platforms to collect patient data.
Biomedical Systems, a global provider of centralized diagnostic services, launched its second generation clinical outcome assessment software offering three platforms to collect patient data: the home, investigative site and the web. In addition, the Android smartphone is part of the home technology and the Android tablet is used at the site. Biomedical Systems provides eCOA technology along with cardiac safety, pulmonary function and imaging centralized diagnostic services.
The second version eCOA technology, updating the first which launched in January 2013, now includes the following features:
- More flexible software
- Improved compliance
- Improved ease of use for both sites and patients
- More reliable data transmission
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
